Public COA audit

Retatrutide

Audited September 4, 2026

Mostly consistent, with concerns

Several fields check out, but we found issues worth reviewing before you rely on this document.

Legitimacy
72
Confidence
85%
Panels
2/7
Purity (printed)
99.74%

Scored moderately because the document is mostly consistent but carries soft concerns, limited panel coverage (2/7), 2 soft concerns, and notable note: "High purity confirmed". To improve: include identity, purity, and endotoxin at minimum.

Document details

Fields extracted from the certificate — not order or payment data.

Batch / lot
RT30-26RC08
Identity method
GLP-1 peptide blind test (Semaglutide, Tirzepatide and Retatrutide)
Sample date
2026-08-13
Issue date
2026-08-18

Original certificate

Embedded copy of the stored COA PDF or image. Download it for your records — PeptIQ’s audit is separate from the lab document itself.

Loading original certificate…

7-panel checklist

Had data + good, had data + bad, reported without pass/fail, or missing. Missing lowers thoroughness — you decide whether that panel matters; PeptIQ’s score still factors coverage.

2 of 7 present · 2 passed · 0 failed · 0 reported · 5 missing

Missing is a thoroughness gap — not automatically bad. PeptIQ’s legitimacy score still weighs panel coverage; you can down-weight panels that don’t matter for your use case.

  • Identity

    Tested · passed · core

    Compound identity confirmed (e.g. HPLC, mass spec).

    Retatrutide identified via GLP-1 peptide blind test

  • Purity

    Tested · passed · core

    Reported purity percentage for the analyte.

    99.794%; 99.743%

  • Heavy metals

    Not on this certificate file

    Lead, arsenic, cadmium, mercury, or similar limits.

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

  • Microbial

    Not on this certificate file

    Bioburden / microbial limits testing.

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

  • Endotoxin

    Not on this certificate file · core

    LAL or chromogenic endotoxin assay.

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

  • Sterility

    Not on this certificate file

    Sterility testing where applicable.

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

  • Residual solvent / water

    Not on this certificate file

    Residual solvents or water content limits.

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

How to read this

Had data · good

Panel present with a pass (or clear acceptance).

Had data · bad

Panel present with a fail — a concrete quality signal.

Had data · unclear

Value reported without an explicit pass/fail mark.

Missing on this file

Not on this certificate file. Lowers file thoroughness; a sibling endotoxin/purity report for the same lot may still exist. PeptIQ’s score still factors coverage.

Findings

Evidence-linked observations from this audit.

  • High purity confirmed

    Purity reported as 99.794% and 99.743% (dual measurement), which is excellent for research peptides and within normal range for high-quality synthesis.

  • Identity confirmed via blind test

    Sample identified as Retatrutide through GLP-1 peptide blind test methodology, which tests against Semaglutide, Tirzepatide, and Retatrutide.

  • Batch number present

    Batch RT30-26RC08 clearly documented.

  • Dates are valid and logical

    Testing ordered 07 AUG 2026, sample received 13 AUG 2026, analysis conducted 18 AUG 2026. All dates are sequential and on or before today (2026-09-04).

  • Known testing laboratory

    Janoshik Analytical is a recognized third-party testing lab in the peptide/research compound space with verification system.

  • Verification key provided

    Unique verification key SNVBDC83CLF4 provided with URL www.janoshik.com/verify/ for independent verification.

  • Limited testing scope

    This report covers identity and purity only. No heavy metals, microbial, endotoxin, sterility, or residual solvent testing is included in this particular report. This is common for basic peptide testing but limits safety assessment.

  • Sample description references external attachment

    Sample description states 'See picture or pictures attached' but no additional pages are visible in this submission. This may indicate incomplete document submission.

  • Professional presentation

    Report follows standard Janoshik format with clear sections, QR code, signature field, and structured data presentation.

PeptIQ COA reports analyze document content and publicly verifiable lab signals. They are educational and not a guarantee of product quality, legality, or safety. Always consult a qualified professional before making health decisions. We never publish purchase prices, shipping details, or uploader identity.